Healthcare Sector Stocks
The Healthcare sector has a total of 1058 stocks, with a combined market cap of $8.34 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 41.47.
Market Cap
8.34T
Revenue
4.59T
Profits
201.03B
PE Ratio
41.47
Profit Margin
4.38%
Dividend Yield
0.42%
1059 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 979.64B | - | 4,470,535 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 549.78B | -2.48% | 18,989,761 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 382.49B | - | 9,646,079 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 364.13B | - | 11,896,853 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 281.24B | - | 29,521,620 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 271.53B | - | 1,667,045 | 60.44B |
| 7 | NVS | Novartis AG | 268.17B | - | 1,869,631 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 199.08B | -0.76% | 8,996,732 | 50.57B |
| 9 | AMGN | Amgen Inc. | 182.21B | - | 8,151,089 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 172.66B | - | 3,358,552 | 45.20B |
| 11 | ABT | Abbott Laboratories | 153.99B | -0.10% | 41,964,841 | 45.13B |
| 12 | GILD | Gilead Sciences, Inc. | 153.66B | - | 14,348,343 | 29.74B |
| 13 | ISRG | Intuitive Surgical, Inc. | 144.07B | - | 4,404,201 | 10.58B |
| 14 | PFE | Pfizer Inc. | 143.68B | -2.74% | 119,614,339 | 63.32B |
| 15 | CVS | CVS Health Corporation | 125.45B | - | 21,578,829 | 405.62B |
| 16 | DHR | Danaher Corporation | 125.40B | -0.33% | 7,258,518 | 24.78B |
| 17 | SYK | Stryker Corporation | 118.00B | - | 3,427,962 | 25.27B |
| 18 | VRTX | Vertex Pharmaceuticals Incorporated | 114.63B | - | 2,993,021 | 12.22B |
| 19 | BMY | Bristol-Myers Squibb Company | 110.27B | -2.32% | 31,700,381 | 48.48B |
| 20 | SNY | Sanofi | 102.06B | -0.28% | 4,085,503 | 54.60B |
| 21 | MDT | Medtronic plc | 101.56B | - | 22,656,856 | 36.36B |
| 22 | GSK | GSK plc | 101.50B | - | 4,219,335 | 43.29B |
| 23 | MCK | McKesson Corporation | 87.88B | - | 2,477,060 | 403.43B |
| 24 | ELV | Elevance Health, Inc. | 84.37B | - | 3,536,932 | 200.42B |
| 25 | HCA | HCA Healthcare, Inc. | 83.23B | - | 2,656,836 | 76.39B |
| 26 | CI | The Cigna Group | 73.88B | - | 2,445,957 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 67.32B | - | 30,854,998 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 62.05B | - | 2,609,258 | 14.92B |
| 29 | ARGX | argenx SE | 55.19B | - | 351,970 | 4.74B |
| 30 | COR | Cencora, Inc. | 52.89B | - | 3,408,861 | 328.68B |
| 31 | CAH | Cardinal Health, Inc. | 51.94B | - | 4,196,190 | 250.74B |
| 32 | EW | Edwards Lifesciences Corporation | 50.30B | - | 5,550,252 | 6.30B |
| 33 | TAK | Takeda Pharmaceutical Company Limited | 48.74B | - | 2,442,725 | 28.34B |
| 34 | MDLN | Medline Inc. | 47.21B | - | 15,306,637 | 29.14B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 44.34B | - | 1,240,833 | 4.45B |
| 36 | HUM | Humana Inc. | 43.30B | - | 3,571,219 | 137.20B |
| 37 | BDX | Becton, Dickinson and Company | 39.67B | - | 6,231,988 | 22.23B |
| 38 | HLN | Haleon plc | 39.01B | - | 18,834,669 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 37.13B | - | 2,204,704 | 4.29B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 36.66B | -3.32% | 12,241,543 | 17.35B |
| 41 | A | Agilent Technologies, Inc. | 35.89B | - | 4,334,372 | 7.23B |
| 42 | WAT | Waters Corporation | 34.90B | - | 1,460,783 | 3.77B |
| 43 | RVMD | Revolution Medicines, Inc. | 34.65B | - | 4,702,504 | - |
| 44 | NTRA | Natera, Inc. | 33.14B | - | 2,630,815 | 2.50B |
| 45 | ZTS | Zoetis Inc. | 33.00B | - | 17,092,117 | 9.53B |
| 46 | ALC | Alcon Inc. | 31.92B | - | 1,999,191 | 10.63B |
| 47 | RPRX | Royalty Pharma plc | 30.50B | - | 8,608,503 | 2.44B |
| 48 | CNC | Centene Corporation | 30.13B | - | 11,845,954 | 178.33B |
| 49 | ONC | BeOne Medicines AG | 30.03B | - | 367,886 | 5.70B |
| 50 | BIIB | Biogen Inc. | 29.02B | - | 1,729,826 | 9.94B |
| 51 | GEHC | GE HealthCare Technologies Inc. | 28.02B | - | 8,337,312 | 20.98B |
| 52 | IQV | IQVIA Holdings Inc. | 28.00B | - | 3,703,619 | 16.63B |
| 53 | DXCM | DexCom, Inc. | 27.96B | - | 8,572,122 | 4.82B |
| 54 | RMD | ResMed Inc. | 27.24B | - | 3,884,970 | 5.54B |
| 55 | PHG | Koninklijke Philips N.V. | 25.66B | - | 1,496,673 | 20.34B |
| 56 | MRNA | Moderna, Inc. | 25.38B | 3.50% | 24,078,835 | 2.23B |
| 57 | VEEV | Veeva Systems Inc. | 24.90B | -1.00% | 5,108,136 | 3.32B |
| 58 | ILMN | Illumina, Inc. | 24.50B | - | 3,100,677 | 4.39B |
| 59 | WST | West Pharmaceutical Services, Inc. | 23.17B | - | 1,479,259 | 3.22B |
| 60 | MTD | Mettler-Toledo International Inc. | 23.13B | - | 254,448 | 4.09B |
| 61 | BNTX | BioNTech SE | 22.98B | - | 939,598 | 3.23B |
| 62 | UTHR | United Therapeutics Corporation | 22.78B | - | 2,001,977 | 3.17B |
| 63 | ROIV | Roivant Sciences Ltd. | 22.61B | - | 8,263,245 | 8.26M |
| 64 | DGX | Quest Diagnostics Incorporated | 21.59B | - | 1,292,237 | 11.28B |
| 65 | LH | Labcorp Holdings Inc. | 20.98B | - | 1,249,805 | 14.14B |
| 66 | INSM | Insmed Incorporated | 20.76B | - | 23,379,307 | 819.56M |
| 67 | STE | STERIS plc | 19.75B | - | 1,599,130 | 5.94B |
| 68 | INCY | Incyte Corporation | 19.62B | - | 4,058,623 | 5.36B |
| 69 | VTRS | Viatris Inc. | 17.90B | - | 22,642,340 | 14.56B |
| 70 | GH | Guardant Health, Inc. | 17.47B | - | 3,409,024 | 1.08B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 17.02B | - | 4,635,000 | 8.41B |
| 72 | NBIX | Neurocrine Biosciences, Inc. | 15.92B | - | 2,718,236 | 3.10B |
| 73 | GMAB | Genmab A/S | 15.42B | - | 1,809,920 | 3.90B |
| 74 | THC | Tenet Healthcare Corporation | 14.86B | - | 2,603,892 | 21.46B |
| 75 | ASND | Ascendis Pharma A/S | 14.34B | - | 908,473 | 998.25M |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 14.10B | - | 1,906,922 | 4.44B |
| 77 | BTSG | BrightSpring Health Services, Inc. | 13.80B | - | 7,174,166 | 13.65B |
| 78 | DVA | DaVita Inc. | 13.35B | - | 1,388,961 | 13.84B |
| 79 | MEDP | Medpace Holdings, Inc. | 13.14B | - | 472,737 | 2.68B |
| 80 | SOLV | Solventum Corporation | 13.06B | - | 2,337,120 | 8.26B |
| 81 | EXEL | Exelixis, Inc. | 13.05B | - | 6,545,172 | 2.38B |
| 82 | ALGN | Align Technology, Inc. | 13.04B | - | 1,949,707 | 4.10B |
| 83 | BBIO | BridgeBio Pharma, Inc. | 12.98B | - | 3,815,605 | 579.96M |
| 84 | AXSM | Axsome Therapeutics, Inc. | 12.89B | - | 770,864 | 708.24M |
| 85 | COO | The Cooper Companies, Inc. | 12.85B | - | 3,802,105 | 4.23B |
| 86 | SNN | Smith & Nephew plc | 12.63B | - | 1,046,788 | 6.16B |
| 87 | FMS | Fresenius Medical Care AG | 12.54B | - | 405,739 | 22.32B |
| 88 | PEN | Penumbra, Inc. | 12.48B | - | 679,710 | 1.45B |
| 89 | IONS | Ionis Pharmaceuticals, Inc. | 12.25B | - | 2,984,374 | 1.06B |
| 90 | ELAN | Elanco Animal Health Incorporated | 12.10B | - | 10,243,972 | 4.89B |
| 91 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.66B | - | 486,993 | 1.13B |
| 92 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.52B | - | 3,863,403 | 622.01M |
| 93 | RDY | Dr. Reddy's Laboratories Limited | 11.22B | - | 2,007,810 | 3.58B |
| 94 | ICLR | ICON Public Limited Company | 11.18B | - | 870,065 | 8.25B |
| 95 | RVTY | Revvity, Inc. | 11.16B | - | 2,170,304 | 2.90B |
| 96 | GMED | Globus Medical, Inc. | 10.76B | - | 3,629,867 | 3.10B |
| 97 | CYTK | Cytokinetics, Incorporated | 10.70B | - | 3,547,472 | 105.82M |
| 98 | SMMT | Summit Therapeutics Inc. | 10.67B | - | 8,723,161 | - |
| 99 | BMRN | BioMarin Pharmaceutical Inc. | 10.57B | - | 3,481,457 | 3.24B |
| 100 | BAX | Baxter International Inc. | 10.27B | - | 11,167,906 | 11.32B |
| 101 | KRYS | Krystal Biotech, Inc. | 10.26B | - | 811,433 | 417.30M |
| 102 | MOH | Molina Healthcare, Inc. | 10.18B | - | 1,029,705 | 43.10B |
| 103 | PODD | Insulet Corporation | 10.10B | - | 2,864,145 | 2.90B |
| 104 | NUVL | Nuvalent, Inc. | 9.75B | - | 4,603,597 | - |
| 105 | EHC | Encompass Health Corporation | 9.72B | - | 1,643,923 | 6.07B |
| 106 | TEM | Tempus AI, Inc. | 9.13B | 4.20% | 5,925,856 | 1.36B |
| 107 | HSIC | Henry Schein, Inc. | 9.10B | - | 2,084,117 | 13.38B |
| 108 | TECH | Bio-Techne Corporation | 9.07B | - | 3,773,095 | 1.21B |
| 109 | CRL | Charles River Laboratories International, Inc. | 8.91B | - | 1,170,071 | 4.03B |
| 110 | ENSG | The Ensign Group, Inc. | 8.91B | - | 2,211,354 | 5.27B |
| 111 | BRKR | Bruker Corporation | 8.71B | - | 1,979,645 | 3.46B |
| 112 | CORT | Corcept Therapeutics Incorporated | 8.58B | - | 1,875,598 | 769.10M |
| 113 | OSCR | Oscar Health, Inc. | 8.55B | - | 6,781,285 | 13.30B |
| 114 | UHS | Universal Health Services, Inc. | 8.55B | - | 2,192,983 | 17.76B |
| 115 | HIMS | Hims & Hers Health, Inc. | 8.21B | 11.23% | 31,903,478 | 2.37B |
| 116 | HALO | Halozyme Therapeutics, Inc. | 8.13B | - | 3,654,031 | 1.51B |
| 117 | PRAX | Praxis Precision Medicines, Inc. | 7.87B | - | 698,565 | 7.46M |
| 118 | ABVX | ABIVAX Société Anonyme | 7.77B | - | 1,701,700 | 5.67M |
| 119 | IBRX | ImmunityBio, Inc. | 7.71B | 5.29% | 14,372,395 | 140.98M |
| 120 | ATR | AptarGroup, Inc. | 7.68B | - | 750,611 | 3.87B |
| 121 | GKOS | Glaukos Corporation | 7.67B | - | 984,180 | 551.35M |
| 122 | SYRE | Spyre Therapeutics, Inc. | 7.67B | - | 2,420,430 | - |
| 123 | QGEN | Qiagen N.V. | 7.64B | - | 1,964,098 | 2.10B |
| 124 | BIO | Bio-Rad Laboratories, Inc. | 7.56B | - | 402,770 | 2.59B |
| 125 | TGTX | TG Therapeutics, Inc. | 7.54B | - | 7,172,563 | 700.35M |
| 126 | ALKS | Alkermes plc | 7.50B | - | 7,751,437 | 1.56B |
| 127 | RGEN | Repligen Corporation | 7.45B | - | 1,236,920 | 763.34M |
| 128 | KYMR | Kymera Therapeutics, Inc. | 7.44B | - | 1,262,295 | 51.48M |
| 129 | PCVX | Vaxcyte, Inc. | 7.43B | - | 2,837,044 | - |
| 130 | PTGX | Protagonist Therapeutics, Inc. | 7.26B | - | 1,533,672 | 74.06M |
| 131 | IMVT | Immunovant, Inc. | 7.26B | - | 3,888,370 | - |
| 132 | HQY | HealthEquity, Inc. | 7.12B | - | 1,200,782 | 1.34B |
| 133 | APGE | Apogee Therapeutics, Inc. | 6.77B | - | 1,970,054 | - |
| 134 | LNTH | Lantheus Holdings, Inc. | 6.76B | - | 1,090,899 | 1.55B |
| 135 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.63B | - | 1,558,968 | 217.17M |
| 136 | PTCT | PTC Therapeutics, Inc. | 6.55B | - | 2,870,286 | 827.11M |
| 137 | AVTR | Avantor, Inc. | 6.54B | - | 8,042,325 | 6.55B |
| 138 | MIRM | Mirum Pharmaceuticals, Inc. | 6.53B | - | 1,576,815 | 569.61M |
| 139 | GRFS | Grifols, S.A. | 6.38B | - | 1,025,911 | 8.58B |
| 140 | LQDA | Liquidia Corporation | 6.32B | - | 12,434,080 | 288.07M |
| 141 | CNTA | Centessa Pharmaceuticals plc | 6.19B | - | 5,588,743 | 15.00M |
| 142 | RGC | Regencell Bioscience Holdings Limited | 5.95B | - | 380,694 | - |
| 143 | COGT | Cogent Biosciences, Inc. | 5.90B | - | 4,898,258 | - |
| 144 | PACS | PACS Group, Inc. | 5.79B | - | 1,092,839 | 5.43B |
| 145 | CHE | Chemed Corporation | 5.77B | - | 541,056 | 2.54B |
| 146 | BLTE | Belite Bio, Inc | 5.75B | - | 255,109 | - |
| 147 | SRRK | Scholar Rock Holding Corporation | 5.67B | - | 3,059,292 | - |
| 148 | TFX | Teleflex Incorporated | 5.62B | - | 557,458 | 2.13B |
| 149 | LGND | Ligand Pharmaceuticals Incorporated | 5.51B | - | 609,561 | 274.48M |
| 150 | TWST | Twist Bioscience Corporation | 5.45B | - | 3,938,867 | 409.48M |
| 151 | CGON | CG Oncology, Inc. | 5.39B | - | 2,259,044 | 5.07M |
| 152 | HNGE | Hinge Health, Inc. | 5.37B | - | 2,826,521 | 646.34M |
| 153 | BLCO | Bausch + Lomb Corporation | 5.30B | - | 335,472 | 5.21B |
| 154 | CAI | Caris Life Sciences, Inc. | 5.22B | - | 2,398,379 | 907.29M |
| 155 | CRSP | CRISPR Therapeutics AG | 5.22B | 1.88% | 1,941,408 | 4.10M |
| 156 | LEGN | Legend Biotech Corporation | 5.19B | - | 13,608,397 | 1.14B |
| 157 | AMRX | Amneal Pharmaceuticals, Inc. | 5.17B | - | 2,874,909 | 3.05B |
| 158 | TVTX | Travere Therapeutics, Inc. | 5.13B | - | 6,587,102 | 536.20M |
| 159 | XENE | Xenon Pharmaceuticals Inc. | 5.11B | - | 1,927,662 | 7.50M |
| 160 | BLLN | BillionToOne, Inc. | 4.84B | - | 985,190 | 354.54M |
| 161 | STVN | Stevanato Group S.p.A. | 4.79B | - | 263,916 | 1.39B |
| 162 | ALHC | Alignment Healthcare, Inc. | 4.52B | - | 7,257,260 | 4.26B |
| 163 | SHC | Sotera Health Company | 4.51B | - | 3,180,976 | 1.19B |
| 164 | DNTH | Dianthus Therapeutics, Inc. | 4.51B | - | 2,478,108 | 1.34M |
| 165 | TXG | 10x Genomics, Inc. | 4.41B | - | 3,608,801 | 638.78M |
| 166 | ORKA | Oruka Therapeutics, Inc. | 4.36B | 2.06% | 2,986,885 | - |
| 167 | LIVN | LivaNova PLC | 4.31B | - | 1,427,477 | 1.43B |
| 168 | CELC | Celcuity Inc. | 4.28B | - | 2,126,823 | - |
| 169 | VCYT | Veracyte, Inc. | 4.28B | - | 4,155,448 | 541.74M |
| 170 | ERAS | Erasca, Inc. | 4.25B | - | 9,642,125 | - |
| 171 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.24B | - | 780,968 | 754.05M |
| 172 | RDNT | RadNet, Inc. | 4.23B | - | 2,522,418 | 2.14B |
| 173 | NVST | Envista Holdings Corporation | 4.22B | - | 3,901,399 | 2.81B |
| 174 | MMED | MiniMed Group, Inc. | 4.15B | - | 2,855,024 | 3.10B |
| 175 | TNGX | Tango Therapeutics, Inc. | 4.05B | - | 12,095,877 | 56.99M |
| 176 | MMSI | Merit Medical Systems, Inc. | 4.01B | - | 1,182,124 | 1.54B |
| 177 | EWTX | Edgewise Therapeutics, Inc. | 3.96B | - | 2,007,584 | - |
| 178 | MANE | Veradermics, Incorporated | 3.92B | - | 826,641 | - |
| 179 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.84B | - | 3,354,254 | 596.96M |
| 180 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.78B | - | 2,013,875 | 18.07M |
| 181 | DOCS | Doximity, Inc. | 3.74B | - | 4,484,105 | 644.86M |
| 182 | ACAD | ACADIA Pharmaceuticals Inc. | 3.70B | - | 3,225,717 | 1.10B |
| 183 | DNLI | Denali Therapeutics Inc. | 3.70B | - | 2,518,393 | - |
| 184 | CON | Concentra Group Holdings Parent, Inc. | 3.65B | - | 1,399,584 | 2.23B |
| 185 | WAY | Waystar Holding Corp. | 3.54B | - | 3,747,529 | 1.16B |
| 186 | VKTX | Viking Therapeutics, Inc. | 3.53B | - | 3,395,661 | - |
| 187 | OGN | Organon & Co. | 3.53B | - | 5,074,607 | 6.16B |
| 188 | ICUI | ICU Medical, Inc. | 3.51B | - | 506,719 | 2.16B |
| 189 | NAMS | NewAmsterdam Pharma Company N.V. | 3.49B | - | 1,250,184 | 22.57M |
| 190 | LFST | LifeStance Health Group, Inc. | 3.48B | - | 6,914,940 | 1.49B |
| 191 | RLAY | Relay Therapeutics, Inc. | 3.46B | - | 10,738,974 | 10.68M |
| 192 | OPCH | Option Care Health, Inc. | 3.45B | - | 3,557,992 | 5.67B |
| 193 | TLX | Telix Pharmaceuticals Limited | 3.45B | - | 90,462 | 803.79M |
| 194 | IRTC | iRhythm Holdings, Inc. | 3.44B | - | 626,318 | 787.85M |
| 195 | BEAM | Beam Therapeutics Inc. | 3.40B | - | 3,509,471 | 164.01M |
| 196 | HAE | Haemonetics Corporation | 3.37B | - | 887,719 | 1.33B |
| 197 | PBLS | Parabilis Medicines, Inc. | 3.29B | - | 685,074 | - |
| 198 | ARQT | Arcutis Biotherapeutics, Inc. | 3.28B | - | 5,480,646 | 415.62M |
| 199 | DYN | Dyne Therapeutics, Inc. | 3.27B | - | 5,111,972 | - |
| 200 | BKD | Brookdale Senior Living Inc. | 3.26B | - | 3,537,610 | 3.00B |
| 201 | WRBY | Warby Parker Inc. | 3.19B | - | 18,818,531 | 890.57M |
| 202 | GPCR | Structure Therapeutics Inc. | 3.16B | - | 1,152,053 | - |
| 203 | NHC | National HealthCare Corporation | 3.15B | - | 667,246 | 1.53B |
| 204 | ITGR | Integer Holdings Corporation | 3.09B | - | 581,346 | 1.86B |
| 205 | RCUS | Arcus Biosciences, Inc. | 3.06B | - | 2,309,066 | 236.00M |
| 206 | ALMS | Alumis Inc. | 2.98B | - | 1,883,737 | 8.40M |
| 207 | PRVA | Privia Health Group, Inc. | 2.98B | - | 1,925,572 | 2.25B |
| 208 | QURE | uniQure N.V. | 2.92B | - | 4,859,906 | 18.09M |
| 209 | HTFL | HeartFlow, Inc. | 2.90B | - | 1,805,498 | 191.42M |
| 210 | ADPT | Adaptive Biotechnologies Corporation | 2.81B | - | 3,883,148 | 295.41M |
| 211 | ELVN | Enliven Therapeutics, Inc. | 2.75B | - | 2,449,817 | - |
| 212 | IDYA | IDEAYA Biosciences, Inc. | 2.74B | - | 2,018,517 | 225.27M |
| 213 | GRAL | GRAIL, Inc. | 2.74B | - | 1,164,791 | 156.12M |
| 214 | TMDX | TransMedics Group, Inc. | 2.72B | - | 1,788,086 | 635.89M |
| 215 | TARS | Tarsus Pharmaceuticals, Inc. | 2.72B | - | 402,143 | 535.08M |
| 216 | IRON | Disc Medicine, Inc. | 2.70B | - | 1,562,335 | - |
| 217 | RARE | Ultragenyx Pharmaceutical Inc. | 2.69B | - | 3,562,450 | 670.00M |
| 218 | GRDN | Guardian Pharmacy Services, Inc. | 2.69B | - | 1,002,697 | 1.46B |
| 219 | DFTX | Definium Therapeutics, Inc. | 2.67B | 0.20% | 2,629,893 | - |
| 220 | CLOV | Clover Health Investments, Corp. | 2.63B | - | 7,152,184 | 2.21B |
| 221 | KLRA | Kailera Therapeutics, Inc. | 2.58B | - | 4,355,889 | - |
| 222 | SUPN | Supernus Pharmaceuticals, Inc. | 2.58B | - | 1,096,030 | 776.83M |
| 223 | CLDX | Celldex Therapeutics, Inc. | 2.55B | - | 2,378,576 | 865.00K |
| 224 | VERA | Vera Therapeutics, Inc. | 2.52B | - | 1,497,554 | - |
| 225 | ESTA | Establishment Labs Holdings Inc. | 2.50B | - | 495,481 | 229.58M |
| 226 | TRVI | Trevi Therapeutics, Inc. | 2.44B | 5.13% | 2,960,142 | - |
| 227 | AXGN | Axogen, Inc. | 2.38B | - | 1,295,828 | 238.11M |
| 228 | BFLY | Butterfly Network, Inc. | 2.33B | 55.87% | 60,480,073 | 102.92M |
| 229 | PHVS | Pharvaris N.V. | 2.29B | - | 182,167 | - |
| 230 | ACHC | Acadia Healthcare Company, Inc. | 2.29B | - | 3,076,582 | 3.37B |
| 231 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.28B | - | 8,882,726 | 885.72M |
| 232 | KOD | Kodiak Sciences Inc. | 2.26B | - | 1,205,936 | - |
| 233 | PBH | Prestige Consumer Healthcare Inc. | 2.23B | - | 1,270,345 | 1.09B |
| 234 | NTLA | Intellia Therapeutics, Inc. | 2.19B | 3.09% | 8,849,172 | 66.09M |
| 235 | LMAT | LeMaitre Vascular, Inc. | 2.15B | - | 724,887 | 256.28M |
| 236 | IMNM | Immunome, Inc. | 2.12B | - | 3,318,517 | 4.02M |
| 237 | AUPH | Aurinia Pharmaceuticals Inc. | 2.12B | 1.98% | 1,172,338 | 298.30M |
| 238 | XRAY | DENTSPLY SIRONA Inc. | 2.07B | - | 5,316,378 | 3.68B |
| 239 | OCUL | Ocular Therapeutix, Inc. | 2.06B | - | 6,114,284 | 52.04M |
| 240 | NKTR | Nektar Therapeutics | 2.06B | 0.10% | 909,591 | 55.63M |
| 241 | SEM | Select Medical Holdings Corporation | 2.05B | - | 1,746,832 | 5.52B |
| 242 | MBX | MBX Biosciences, Inc. | 2.05B | - | 832,199 | - |
| 243 | VCEL | Vericel Corporation | 2.05B | - | 1,686,309 | 292.09M |
| 244 | BHVN | Biohaven Ltd. | 2.04B | - | 6,458,979 | - |
| 245 | PGNY | Progyny, Inc. | 2.04B | - | 3,065,148 | 1.29B |
| 246 | ZLAB | Zai Lab Limited | 2.04B | - | 978,130 | 453.28M |
| 247 | MLYS | Mineralys Therapeutics, Inc. | 2.03B | - | 4,062,205 | - |
| 248 | AGIO | Agios Pharmaceuticals, Inc. | 2.03B | - | 2,241,589 | 66.05M |
| 249 | NEOG | Neogen Corporation | 2.03B | - | 5,065,589 | 870.56M |
| 250 | KARD | Kardigan, Inc. | 1.97B | 37.50% | 5,844,443 | - |
| 251 | TRLV | Trulieve Cannabis Corp. | 1.94B | - | 3,221,815 | 1.17B |
| 252 | ASTH | Astrana Health, Inc. | 1.94B | - | 936,294 | 3.53B |
| 253 | NUVB | Nuvation Bio Inc. | 1.94B | - | 4,730,293 | 143.05M |
| 254 | MESO | Mesoblast Limited | 1.94B | - | 126,036 | 65.38M |
| 255 | STOK | Stoke Therapeutics, Inc. | 1.93B | - | 1,971,081 | 32.08M |
| 256 | HRMY | Harmony Biosciences Holdings, Inc. | 1.93B | - | 770,605 | 899.11M |
| 257 | ADMA | ADMA Biologics, Inc. | 1.93B | - | 8,921,995 | 509.86M |
| 258 | AGL | agilon health, inc. | 1.90B | - | 417,105 | 5.82B |
| 259 | MD | Pediatrix Medical Group, Inc. | 1.89B | - | 2,146,163 | 1.93B |
| 260 | SGRY | Surgery Partners, Inc. | 1.89B | - | 2,306,086 | 3.34B |
| 261 | LKFT | Lakefront Biotherapeutics NV | 1.86B | - | 159,488 | 1.20B |
| 262 | GENB | Generate Biomedicines, Inc. | 1.86B | 4.47% | 2,604,818 | 30.30M |
| 263 | UFPT | UFP Technologies, Inc. | 1.85B | - | 227,489 | 608.85M |
| 264 | SRPT | Sarepta Therapeutics, Inc. | 1.85B | 3.36% | 5,610,425 | 2.18B |
| 265 | TSHA | Taysha Gene Therapies, Inc. | 1.84B | - | 6,368,907 | 7.47M |
| 266 | VRDN | Viridian Therapeutics, Inc. | 1.84B | - | 4,032,028 | 70.92M |
| 267 | NRIX | Nurix Therapeutics, Inc. | 1.81B | - | 4,250,980 | 71.78M |
| 268 | HCM | HUTCHMED (China) Limited | 1.80B | - | 50,336 | 548.51M |
| 269 | RAPP | Rapport Therapeutics, Inc. | 1.79B | - | 355,436 | 20.00M |
| 270 | BHC | Bausch Health Companies Inc. | 1.78B | 0.21% | 4,410,314 | 10.53B |
| 271 | OMCL | Omnicell, Inc. | 1.78B | - | 1,347,205 | 1.23B |
| 272 | PLSE | Pulse Biosciences, Inc. | 1.77B | - | 364,271 | 751.00K |
| 273 | NBTX | Nanobiotix S.A. | 1.76B | - | 49,584 | 38.27M |
| 274 | WGS | GeneDx Holdings Corp. | 1.75B | - | 658,704 | 442.68M |
| 275 | IOVA | Iovance Biotherapeutics, Inc. | 1.75B | - | 23,714,726 | 285.61M |
| 276 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.74B | - | 1,293,016 | -665.00K |
| 277 | ADUS | Addus HomeCare Corporation | 1.72B | - | 389,809 | 1.45B |
| 278 | PGEN | Precigen, Inc. | 1.72B | - | 4,755,744 | 31.60M |
| 279 | RXRX | Recursion Pharmaceuticals, Inc. | 1.71B | 3.86% | 24,853,721 | 66.41M |
| 280 | AVAH | Aveanna Healthcare Holdings Inc. | 1.70B | - | 2,836,166 | 2.52B |
| 281 | CMPS | COMPASS Pathways plc | 1.69B | - | 3,625,330 | - |
| 282 | ZYME | Zymeworks Inc. | 1.69B | - | 699,025 | 81.26M |
| 283 | ABCL | AbCellera Biologics Inc. | 1.69B | - | 6,803,880 | 79.21M |
| 284 | ANIP | ANI Pharmaceuticals, Inc. | 1.69B | - | 351,456 | 923.71M |
| 285 | TYRA | Tyra Biosciences, Inc. | 1.68B | - | 2,561,457 | - |
| 286 | SION | Sionna Therapeutics, Inc. | 1.68B | - | 736,762 | - |
| 287 | SNDX | Syndax Pharmaceuticals, Inc. | 1.68B | - | 3,994,897 | 217.17M |
| 288 | SNDA | Sonida Senior Living, Inc. | 1.68B | - | 2,537,879 | 367.34M |
| 289 | ANAB | AnaptysBio, Inc. | 1.67B | - | 827,833 | 232.39M |
| 290 | INVA | Innoviva, Inc. | 1.66B | - | 1,403,827 | 420.69M |
| 291 | NVCR | NovoCure Limited | 1.65B | - | 4,850,209 | 674.41M |
| 292 | CAPR | Capricor Therapeutics, Inc. | 1.64B | 1.54% | 3,095,680 | 11.13M |
| 293 | URGN | UroGen Pharma Ltd. | 1.64B | - | 847,100 | 140.49M |
| 294 | SEPN | Septerna, Inc. | 1.63B | - | 283,356 | 72.26M |
| 295 | PVLA | Palvella Therapeutics, Inc. | 1.62B | - | 383,247 | - |
| 296 | HROW | Harrow, Inc. | 1.60B | 2.22% | 1,071,358 | 268.68M |
| 297 | HCSG | Healthcare Services Group, Inc. | 1.57B | - | 1,686,563 | 1.85B |
| 298 | GLUE | Monte Rosa Therapeutics, Inc. | 1.55B | - | 2,507,725 | 42.95M |
| 299 | VIR | Vir Biotechnology, Inc. | 1.54B | - | 8,795,300 | 65.50M |
| 300 | AAPG | Ascentage Pharma Group International | 1.54B | - | 12,802 | 82.08M |
| 301 | BCAX | Bicara Therapeutics Inc. | 1.53B | - | 1,934,590 | - |
| 302 | GHRS | GH Research PLC | 1.53B | - | 544,656 | - |
| 303 | ALMR | Alamar Biosciences, Inc. | 1.52B | - | 996,569 | 87.16M |
| 304 | NVAX | Novavax, Inc. | 1.50B | - | 9,458,291 | 596.34M |
| 305 | SLS | SELLAS Life Sciences Group, Inc. | 1.50B | 3.74% | 14,747,756 | - |
| 306 | ATAI | AtaiBeckley Inc. | 1.49B | - | 6,624,979 | 3.49M |
| 307 | ARDX | Ardelyx, Inc. | 1.49B | - | 9,839,094 | 427.68M |
| 308 | AVBP | ArriVent BioPharma, Inc. | 1.48B | - | 859,254 | - |
| 309 | ATRC | AtriCure, Inc. | 1.46B | - | 1,731,572 | 552.16M |
| 310 | TDOC | Teladoc Health, Inc. | 1.46B | - | 5,836,894 | 2.51B |
| 311 | IMCR | Immunocore Holdings plc | 1.45B | - | 812,334 | 412.81M |
| 312 | STAA | STAAR Surgical Company | 1.45B | - | 818,048 | 290.38M |
| 313 | NEO | NeoGenomics, Inc. | 1.45B | - | 6,707,589 | 745.97M |
| 314 | FTRE | Fortrea Holdings Inc. | 1.45B | - | 3,008,147 | 2.71B |
| 315 | MAZE | Maze Therapeutics, Inc. | 1.42B | - | 1,390,455 | 20.00M |
| 316 | PRGO | Perrigo Company plc | 1.42B | - | 5,131,295 | 4.18B |
| 317 | MLTX | MoonLake Immunotherapeutics | 1.41B | 0.10% | 774,519 | - |
| 318 | SVRA | Savara Inc. | 1.39B | - | 4,761,570 | - |
| 319 | IART | Integra LifeSciences Holdings Corporation | 1.37B | - | 2,322,863 | 1.64B |
| 320 | INBX | Inhibrx Biosciences, Inc. | 1.37B | - | 473,549 | 1.30M |
| 321 | ATEC | Alphatec Holdings, Inc. | 1.35B | - | 4,526,787 | 787.08M |
| 322 | CDNA | CareDx, Inc. | 1.35B | - | 2,744,752 | 412.82M |
| 323 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.34B | - | 9,280,186 | 204.73M |
| 324 | IMTX | Immatics N.V. | 1.34B | - | 438,424 | 43.00M |
| 325 | AKTS | Aktis Oncology, Inc. | 1.33B | - | 552,135 | 8.28M |
| 326 | AVLN | Avalyn Pharma Inc. | 1.31B | - | 1,515,229 | - |
| 327 | ALVO | Alvotech | 1.31B | 0.13% | 1,080,458 | 562.04M |
| 328 | MPLT | MapLight Therapeutics, Inc. | 1.31B | - | 1,466,886 | - |
| 329 | DMRA | Damora Therapeutics, Inc. | 1.31B | - | 1,747,141 | - |
| 330 | COAG | Hemab Therapeutics Holdings, Inc. | 1.29B | - | 1,548,237 | - |
| 331 | PAHC | Phibro Animal Health Corporation | 1.29B | - | 439,871 | 1.50B |
| 332 | AHCO | AdaptHealth Corp. | 1.28B | - | 2,315,746 | 3.29B |
| 333 | ARDT | Ardent Health, Inc. | 1.28B | - | 505,788 | 6.43B |
| 334 | BLFS | BioLife Solutions, Inc. | 1.27B | - | 1,117,752 | 101.66M |
| 335 | ENOV | Enovis Corporation | 1.26B | - | 1,799,377 | 2.28B |
| 336 | ZBIO | Zenas BioPharma, Inc. | 1.25B | - | 2,128,326 | 10.00M |
| 337 | PRCT | PROCEPT BioRobotics Corporation | 1.24B | - | 1,781,469 | 322.02M |
| 338 | INSP | Inspire Medical Systems, Inc. | 1.23B | - | 1,386,543 | 915.25M |
| 339 | INNV | InnovAge Holding Corp. | 1.22B | - | 990,532 | 949.17M |
| 340 | MNKD | MannKind Corporation | 1.22B | - | 16,622,952 | 360.78M |
| 341 | AMN | AMN Healthcare Services, Inc. | 1.20B | - | 1,189,094 | 3.42B |
| 342 | XERS | Xeris Biopharma Holdings, Inc. | 1.20B | - | 2,398,786 | 314.85M |
| 343 | WVE | Wave Life Sciences Ltd. | 1.19B | - | 5,099,122 | 71.80M |
| 344 | IRMD | IRADIMED CORPORATION | 1.18B | - | 182,288 | 86.28M |
| 345 | SDGR | Schrödinger, Inc. | 1.18B | - | 1,556,415 | 254.91M |
| 346 | AVNS | Avanos Medical, Inc. | 1.17B | - | 2,998,096 | 715.90M |
| 347 | KMTS | Kestra Medical Technologies, Ltd. | 1.16B | - | 398,794 | 83.72M |
| 348 | PNTG | The Pennant Group, Inc. | 1.16B | - | 351,627 | 1.02B |
| 349 | ABSI | Absci Corporation | 1.16B | - | 8,444,166 | 1.84M |
| 350 | AHG | Akso Health Group | 1.15B | - | 5,846 | 14.84M |
| 351 | EYPT | EyePoint, Inc. | 1.14B | - | 1,290,270 | 7.61M |
| 352 | PSNL | Personalis, Inc. | 1.10B | - | 3,823,116 | 64.52M |
| 353 | COLL | Collegium Pharmaceutical, Inc. | 1.09B | - | 631,903 | 796.33M |
| 354 | AZTA | Azenta, Inc. | 1.07B | - | 1,186,478 | 596.48M |
| 355 | OPK | OPKO Health, Inc. | 1.07B | - | 5,231,781 | 581.12M |
| 356 | OMDA | Omada Health, Inc. | 1.05B | - | 788,987 | 283.30M |
| 357 | TNDM | Tandem Diabetes Care, Inc. | 1.05B | - | 2,537,837 | 1.03B |
| 358 | MGTX | MeiraGTx Holdings plc | 1.05B | - | 2,519,937 | 79.76M |
| 359 | NUTX | Nutex Health Inc. | 1.04B | - | 144,434 | 879.95M |
| 360 | AORT | Artivion, Inc. | 1.03B | - | 1,000,724 | 458.69M |
| 361 | CRON | Cronos Group Inc. | 1.00B | - | 1,218,244 | 159.54M |
| 362 | CRVS | Corvus Pharmaceuticals, Inc. | 1.00B | -0.75% | 1,977,181 | - |
| 363 | JBIO | Jade Biosciences, Inc. | 998.43M | - | 4,785,525 | - |
| 364 | CNMD | CONMED Corporation | 980.96M | - | 1,228,142 | 1.37B |
| 365 | SPTX | Seaport Therapeutics, Inc. | 972.65M | - | 1,326,804 | - |
| 366 | USPH | U.S. Physical Therapy, Inc. | 963.65M | - | 253,927 | 787.69M |
| 367 | DBVT | DBV Technologies S.A. | 961.15M | - | 320,273 | 5.74M |
| 368 | SPRY | ARS Pharmaceuticals, Inc. | 958.28M | - | 2,277,986 | 98.99M |
| 369 | AVR | Anteris Technologies Global Corp. | 952.01M | 2.95% | 1,453,976 | 1.85M |
| 370 | SANA | Sana Biotechnology, Inc. | 944.68M | - | 6,743,940 | - |
| 371 | EVO | Evotec SE | 943.89M | - | 40,079 | 859.03M |
| 372 | XNCR | Xencor, Inc. | 937.15M | - | 1,815,288 | 97.36M |
| 373 | SLBT | SL Science Holding Limited | 935.81M | - | 488,769 | - |
| 374 | QDEL | QuidelOrtho Corporation | 932.17M | - | 2,150,326 | 2.66B |
| 375 | CGEM | Cullinan Therapeutics, Inc. | 923.71M | - | 3,117,265 | - |
| 376 | BIOA | BioAge Labs, Inc. | 923.28M | - | 619,615 | 10.32M |
| 377 | PHAR | Pharming Group N.V. | 915.32M | - | 3,254 | 369.49M |
| 378 | LMRI | Lumexa Imaging Holdings, Inc. | 904.12M | - | 906,676 | 1.03B |
| 379 | GDRX | GoodRx Holdings, Inc. | 900.88M | - | 2,098,023 | 787.89M |
| 380 | ODTX | Odyssey Therapeutics, Inc. | 899.61M | - | 1,602,913 | 1.06M |
| 381 | ABUS | Arbutus Biopharma Corporation | 898.80M | - | 5,045,878 | 191.45M |
| 382 | LXRX | Lexicon Pharmaceuticals, Inc. | 892.83M | -1.47% | 3,927,187 | 69.64M |
| 383 | ETON | Eton Pharmaceuticals, Inc. | 889.70M | - | 612,757 | 86.93M |
| 384 | DRTS | Alpha Tau Medical Ltd. | 881.92M | - | 574,439 | - |
| 385 | KURA | Kura Oncology, Inc. | 881.53M | - | 1,700,094 | 71.64M |
| 386 | ORIC | ORIC Pharmaceuticals, Inc. | 878.86M | - | 2,771,346 | - |
| 387 | PCRX | Pacira BioSciences, Inc. | 878.64M | - | 950,971 | 734.86M |
| 388 | TALK | Talkspace, Inc. | 872.74M | - | 3,232,004 | 238.37M |
| 389 | JANX | Janux Therapeutics, Inc. | 867.20M | - | 1,251,142 | 13.73M |
| 390 | PHAT | Phathom Pharmaceuticals, Inc. | 864.20M | - | 1,101,965 | 204.89M |
| 391 | CERT | Certara, Inc. | 861.83M | - | 7,909,792 | 419.75M |
| 392 | LBRX | LB Pharmaceuticals Inc | 860.30M | - | 513,122 | - |
| 393 | TBPH | Theravance Biopharma, Inc. | 854.75M | - | 952,850 | 109.78M |
| 394 | INMD | InMode Ltd. | 849.01M | - | 568,624 | 374.64M |
| 395 | REPL | Replimune Group, Inc. | 841.41M | - | 2,571,740 | - |
| 396 | OLMA | Olema Pharmaceuticals, Inc. | 830.67M | - | 2,868,788 | - |
| 397 | AMPH | Amphastar Pharmaceuticals, Inc. | 829.39M | - | 1,327,603 | 720.53M |
| 398 | SLDB | Solid Biosciences Inc. | 820.09M | - | 14,768,079 | - |
| 399 | ESPR | Esperion Therapeutics, Inc. | 810.91M | -0.63% | 17,496,865 | 418.24M |
| 400 | GERN | Geron Corporation | 808.32M | - | 22,995,892 | 196.12M |
| 401 | ANNX | Annexon, Inc. | 802.83M | - | 7,342,604 | - |
| 402 | ANRO | Alto Neuroscience, Inc. | 798.04M | - | 558,218 | - |
| 403 | VOR | Vor Biopharma Inc. | 785.15M | - | 2,875,028 | - |
| 404 | DSGN | Design Therapeutics, Inc. | 776.96M | - | 1,036,689 | - |
| 405 | AVTX | Avalo Therapeutics, Inc. | 772.71M | - | 6,417,380 | 59.00K |
| 406 | EVMN | Evommune, Inc. | 769.35M | - | 665,146 | 10.00M |
| 407 | ZVRA | Zevra Therapeutics, Inc. | 762.58M | - | 1,948,451 | 122.29M |
| 408 | HSTM | HealthStream, Inc. | 749.08M | - | 315,730 | 311.78M |
| 409 | OMER | Omeros Corporation | 744.02M | - | 2,634,660 | 9.89M |
| 410 | NNNN | Anbio Biotechnology | 730.35M | - | 18,268 | 8.65M |
| 411 | IVA | Inventiva S.A. | 727.77M | - | 3,549,809 | 7.94M |
| 412 | BVS | Bioventus Inc. | 727.59M | - | 1,060,182 | 576.30M |
| 413 | GMRS | GMR Solutions Inc. | 715.66M | - | 4,053,947 | 5.83B |
| 414 | RLMD | Relmada Therapeutics, Inc. | 705.91M | - | 4,106,676 | - |
| 415 | SIBN | SI-BONE, Inc. | 702.49M | - | 469,494 | 206.22M |
| 416 | AURA | Aura Biosciences, Inc. | 699.30M | - | 1,263,808 | - |
| 417 | SSII | SS Innovations International, Inc. | 694.46M | - | 49,563 | 48.47M |
| 418 | ALLO | Allogene Therapeutics, Inc. | 690.31M | - | 23,548,240 | 22.00K |
| 419 | CBLL | CeriBell, Inc. | 684.11M | - | 708,946 | 95.07M |
| 420 | CRMD | CorMedix Inc. | 680.18M | - | 2,521,887 | 400.05M |
| 421 | OCS | Oculis Holding AG | 677.55M | - | 772,599 | 1.40M |
| 422 | CLYM | Climb Bio, Inc. | 655.63M | - | 1,246,874 | - |
| 423 | CTMX | CytomX Therapeutics, Inc. | 642.22M | - | 9,732,498 | 35.54M |
| 424 | CSTL | Castle Biosciences, Inc. | 640.57M | - | 726,610 | 339.92M |
| 425 | ACRS | Aclaris Therapeutics, Inc. | 628.49M | - | 4,322,756 | 8.37M |
| 426 | SGP | SpyGlass Pharma, Inc. | 625.08M | - | 144,288 | - |
| 427 | IMMX | Immix Biopharma, Inc. | 620.78M | - | 7,434,821 | - |
| 428 | BBNX | Beta Bionics, Inc. | 618.52M | - | 1,244,667 | 110.24M |
| 429 | TENX | Tenax Therapeutics, Inc. | 613.10M | - | 2,691,092 | - |
| 430 | RIGL | Rigel Pharmaceuticals, Inc. | 608.90M | - | 972,705 | 299.77M |
| 431 | CADL | Candel Therapeutics, Inc. | 608.88M | - | 8,197,173 | - |
| 432 | DRUG | Bright Minds Biosciences Inc. | 608.01M | - | 239,406 | - |
| 433 | TRAX | First Tracks Biotherapeutics, Inc. | 607.83M | - | 1,915,186 | - |
| 434 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 605.61M | - | 2,293,216 | - |
| 435 | TCMD | Tactile Systems Technology, Inc. | 600.45M | - | 413,890 | 343.52M |
| 436 | DNA | Ginkgo Bioworks Holdings, Inc. | 599.03M | - | 1,545,900 | 151.40M |
| 437 | AQST | Aquestive Therapeutics, Inc. | 590.87M | - | 3,138,143 | 50.27M |
| 438 | CBIO | Crescent Biopharma, Inc. | 587.82M | - | 119,469 | 11.88M |
| 439 | PRME | Prime Medicine, Inc. | 583.39M | - | 3,501,633 | 4.03M |
| 440 | IRWD | Ironwood Pharmaceuticals, Inc. | 582.73M | - | 4,942,494 | 361.51M |
| 441 | BWAY | BrainsWay Ltd. | 581.69M | 3.33% | 255,635 | 56.22M |
| 442 | PHR | Phreesia, Inc. | 579.80M | - | 1,396,504 | 495.59M |
| 443 | GYRE | Gyre Therapeutics, Inc. | 571.07M | - | 85,723 | 117.05M |
| 444 | TECX | Tectonic Therapeutic, Inc. | 566.45M | - | 106,749 | - |
| 445 | TLRY | Tilray Brands, Inc. | 564.21M | - | 3,559,861 | 858.28M |
| 446 | PROK | ProKidney Corp. | 552.77M | - | 578,593 | 889.00K |
| 447 | MDXG | MiMedx Group, Inc. | 546.63M | - | 2,130,569 | 389.42M |
| 448 | CERS | Cerus Corporation | 541.00M | - | 3,293,101 | 216.56M |
| 449 | AGMB | AgomAb Therapeutics NV | 540.74M | - | 188,964 | - |
| 450 | CLPT | ClearPoint Neuro, Inc. | 532.91M | - | 2,080,729 | 40.61M |
| 451 | NPCE | NeuroPace, Inc. | 532.89M | - | 168,471 | 99.53M |
| 452 | TOI | The Oncology Institute, Inc. | 525.91M | - | 2,144,042 | 545.76M |
| 453 | XOMA | XOMA Royalty Corporation | 525.34M | - | 88,326 | 48.56M |
| 454 | ALT | Altimmune, Inc. | 525.08M | - | 11,688,235 | 36.00K |
| 455 | RZLT | Rezolute, Inc. | 524.42M | - | 2,812,694 | - |
| 456 | EIKN | Eikon Therapeutics, Inc. | 520.27M | - | 320,268 | - |
| 457 | FLGT | Fulgent Genetics, Inc. | 511.21M | - | 684,421 | 320.35M |
| 458 | SRTA | Strata Critical Medical, Inc. | 508.78M | - | 2,673,888 | 228.58M |
| 459 | ANGO | AngioDynamics, Inc. | 506.44M | - | 1,195,402 | 313.73M |
| 460 | EVH | Evolent Health, Inc. | 505.04M | - | 2,840,283 | 1.89B |
| 461 | FDMT | 4D Molecular Therapeutics, Inc. | 504.99M | - | 892,231 | 88.24M |
| 462 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 5.42M |
| 463 | CTEV | Claritev Corporation | 501.55M | - | 180,832 | 978.76M |
| 464 | VALN | Valneva SE | 501.36M | - | 13,050 | 180.25M |
| 465 | NGNE | Neurogene Inc. | 498.23M | - | 308,956 | 925.00K |
| 466 | ACHV | Achieve Life Sciences, Inc. | 497.90M | - | 6,945,503 | - |
| 467 | ARVN | Arvinas, Inc. | 494.88M | - | 957,544 | 89.40M |
| 468 | STRO | Sutro Biopharma, Inc. | 490.98M | - | 287,935 | 99.61M |
| 469 | KYTX | Kyverna Therapeutics, Inc. | 490.62M | - | 1,474,213 | - |
| 470 | CTKB | Cytek Biosciences, Inc. | 486.87M | - | 18,260,873 | 204.17M |
| 471 | KIDS | OrthoPediatrics Corp. | 484.68M | - | 140,492 | 243.30M |
| 472 | ASMB | Assembly Biosciences, Inc. | 484.33M | - | 298,863 | 71.10M |
| 473 | ARTV | Artiva Biotherapeutics, Inc. | 477.14M | - | 1,747,772 | 251.00K |
| 474 | MOBI | Mobia Medical, Inc. | 471.47M | - | 804,450 | 32.04M |
| 475 | PRTA | Prothena Corporation plc | 467.51M | - | 1,390,844 | 57.94M |
| 476 | CABA | Cabaletta Bio, Inc. | 463.08M | - | 17,204,400 | - |
| 477 | CCCC | C4 Therapeutics, Inc. | 458.85M | - | 3,426,950 | 34.86M |
| 478 | MNPR | Monopar Therapeutics Inc. | 451.97M | - | 128,113 | - |
| 479 | SOPH | SOPHiA GENETICS SA | 449.45M | - | 445,059 | 81.18M |
| 480 | CTNM | Contineum Therapeutics, Inc. | 446.39M | - | 313,870 | - |
| 481 | VREX | Varex Imaging Corporation | 443.80M | - | 732,829 | 857.50M |
| 482 | INDP | Indaptus Therapeutics, Inc. | 441.65M | - | 301,077 | - |
| 483 | EOLS | Evolus, Inc. | 436.62M | -1.63% | 1,101,794 | 301.79M |
| 484 | FBRX | Forte Biosciences, Inc. | 436.18M | - | 228,693 | - |
| 485 | PACB | Pacific Biosciences of California, Inc. | 434.84M | - | 4,318,169 | 160.03M |
| 486 | VTVT | vTv Therapeutics Inc. | 434.83M | - | 56,213 | 36.84M |
| 487 | MYGN | Myriad Genetics, Inc. | 428.79M | - | 2,436,337 | 829.00M |
| 488 | PRLD | Prelude Therapeutics Incorporated | 428.45M | - | 1,076,627 | 16.72M |
| 489 | OVID | Ovid Therapeutics Inc. | 423.67M | - | 15,348,113 | 7.12M |
| 490 | OCGN | Ocugen, Inc. | 419.77M | 0.81% | 26,269,780 | 4.47M |
| 491 | NRC | NRC Health | 417.83M | - | 357,183 | 138.64M |
| 492 | EPRX | Eupraxia Pharmaceuticals Inc. | 417.47M | - | 471,611 | - |
| 493 | BNTC | Benitec Biopharma Inc. | 417.41M | - | 154,631 | - |
| 494 | WEAV | Weave Communications, Inc. | 413.74M | - | 1,670,690 | 248.72M |
| 495 | IPSC | Century Therapeutics, Inc. | 413.01M | - | 579,840 | 109.16M |
| 496 | EDIT | Editas Medicine, Inc. | 412.81M | - | 3,286,391 | 38.69M |
| 497 | EBS | Emergent BioSolutions Inc. | 412.77M | - | 2,229,025 | 676.80M |
| 498 | SGMT | Sagimet Biosciences Inc. | 412.50M | - | 3,592,541 | - |
| 499 | KMDA | Kamada Ltd. | 412.49M | - | 25,147 | 181.68M |
| 500 | CGC | Canopy Growth Corporation | 410.92M | 2.49% | 2,641,354 | 203.89M |